Optimizing the safety of antibody–drug conjugates for patients with solid tumours

Paolo Tarantino(Dana-Farber Brigham Cancer Center), Biagio Ricciuti(Harvard University), Shan Pradhan(United States Food and Drug Administration), Sara M. Tolaney(Dana-Farber Cancer Institute)
Nature Reviews Clinical Oncology
June 9, 2023
10.1038/s41571-023-00783-w
Cited by 220Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis